Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia Gravis

NCT05045248 is registered in ClinicalTrials.gov with American University of Beirut Medical Center as lead sponsor.

NCT NCT05045248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05045248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia Gravis
Lead sponsor
American University of Beirut Medical Center
Phase
Phase 2
Overall status
Completed
Start date
June 1, 2020
Completion date
April 15, 2021
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myasthenia gravis, ocular myasthenia gravis